Nanopharmaceutics and Advanced Drug Delivery

Regina Herma is PhD candidate and her work is mainly focused on the effect of type, generation and surface modification of carbosilane dendrimers on the interaction with selected nucleic acids for applications in biomedicine (transport molecules for drug targeting, vectors for gene therapy, potential treatment of lung cancer). She is part of a research team for a number of projects.

Bachelor in Pharmacy, Juliana D. Oliveira is currently a PhD student at Department of Biochemistry and Tissue Biology, Institute of Biology / University of Campinas (UNICAMP), Brazil. Has experience in the areas of pharmacology, biochemistry and pharmaceutical technology - working in the development of drug-delivery systems, DDS, mainly ionic gradient liposomes – and Biophysical methods applied to the study of the structural, physicochemical, mechanical and biological properties of DDS.

Samaneh KABIRIAN has her expertise in synthesis, characterization of nanoparticles conjugated to aptamers. and passion in improving its application in biology of cancer. Basically she is chemist and she finished her bachelor in pure chemistry and her master in analytical chemistry in detection of biomolecule in blood. As she is always curious and enthusiastic to work on multidisciplinary project and bridging gap between different domains of science. She is now doing a double degree PhD in molecular and cellular biology at university of Lyon and in parallel Analytical chemistry at Isfahan university-Iran. 3 years studying and working in biochemistry and biology laboratory of cancer research center of Lyon-France gave her a good point of view to biological aspects of applications of Nanoparticles in biology of cancer. With her strong background in chemistry and specially analytical chemistry, She is also trained in all common molecular and cellular biology manipulations like Cell culture, Protein and DNA analysis and so on . Her double skilled ability can build a good connection in multidisciplinary project especially cancer biology and pharmaceutical chemistry.

Keith Moss holds a BSc in Biochemistry and Genetics from the University of Cape Town and an MSc in Engineering in Biotechnology from the Technical University of Denmark (DTU). Now, as a first year PhD student at DTU, Keith is engaged in the development of a novel technology platform for the identification of optimal nanoparticles for therapeutic applications. This project encompasses multiple disciplines and incorporates Keith’s interest in human disease and molecular therapeutics as well as nanotechnology and pharmaceutical drug development.

Robert Prud’homme is a professor in the Department of Chemical and Biological Engineering at Princeton University. He is the founding director of the Program in Engineering Biology. His research program focusses on polymer self-assembly applied to drug delivery. The development of Flash NanoPrecipitation (FNP) in his laboratory enabled the encapsulation of poorly soluble drug compounds and oligonucleotides for therapy directed towards cancer, TB, and injections. FNP is a scalable and continuous process that is enables integrated processing and spray drying for low cost oral and aerosol formulations. Under sponsorship by the Bill and Melinda Gates Foundation, the process is being adopted to formulate new compounds coming from TBA, MMV, and DNDi.